CRISPR Therapeutics AG
CRSP
Market Cap$4.55B
Close$
$-32.84
157.6% downside
Current Fair Value
157.6% downsideOvervalued by 157.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.55 Billion |
|---|---|
| Enterprise Value | $2.44 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.94 |
| Beta | 0.0 |
| Outstanding Shares | 84,918,093 |
| Avg 30 Day Volume | 1,327,823 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -29.6 |
|---|---|
| PEG | -24.73 |
| Price to Sales | 18.99 |
| Price to Book Ratio | 2.37 |
| Enterprise Value to Revenue | 8.98 |
| Enterprise Value to EBIT | -8.17 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni